Study to Evaluate the Long-Term Safety and Efficacy of Imsidolimab (ANB019) in the Treatment of Subjects With GPP
Stopped early · Phase 3 · Has a placebo group
Conditions studied: Generalized Pustular Psoriasis
In brief
This is a Phase 3, long term extension study to evaluate the safety and efficacy of imsidolimab compared with placebo in adult subjects with generalized pustular psoriasis (GPP).
Key facts
- Study ID
- NCT05366855
- Run by
- Vanda Pharmaceuticals
- People needed
- 42
- Starts
- 2022-04-21
- Expected to finish
- 2024-07-12
- Last updated by the study team
- 2026-03-27
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subject participated in the preceding placebo-controlled Phase 3 study ANB019-301 and completed at least the Week 1 visit of the ANB019-301 study without the use of rescue/prohibited medication for GPP
- Subject must be a candidate for prolonged GPP treatment according to the Investigator's judgment
You may not qualify if…
- Use of prohibited medications between the last visit of the ANB019-301 study and the Day 1 visit of the ANB019-302 study
Where it is running
- Site 30-105 — Lodz, Poland
- Site 10-109 — Largo, Florida, United States
- Site 10-105 — Louisville, Kentucky, United States
- Site 10-101 — Ann Arbor, Michigan, United States
- Site 10-108 — Dallas, Texas, United States
- Site 10-102 — Springville, Utah, United States
- Site 35-102 — Melbourne, Victoria, Australia
- Site 16-102 — Nantes, France
- Site 16-101 — Paris, France
- Site 59-104 — Batumi, Georgia
- Site 59-102 — Tbilisi, Georgia
- Site 59-101 — Tbilisi, Georgia
- Site 59-105 — Tbilisi, Georgia
- Site 59-103 — Tbilisi, Georgia
- Site 17-102 — Bad Bentheim, Germany
- Site 17-104 — Bonn, Germany
- Site 17-103 — Hanau, Germany
- Site 17-105 — Würzburg, Germany
- Site 42-106 — Johor Bahru, Johor, Malaysia
- Site 42-107 — Johor Bahru, Johor, Malaysia
- Site 42-102 — Muar town, Johor, Malaysia
- Site 42-105 — Kota Bharu, Kelantan, Malaysia
- Site 42-108 — Kuching, Sarawak, Malaysia
- Site 42-109 — Batu Caves, Selangor, Malaysia
- Site 30-104 — Krakow, Poland
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.